Skip to main content
Clinical Trials/DRKS00026660
DRKS00026660
Recruiting
Not Applicable

Retrospective evaluation of image-guided interventional treatments of venous and arteriovenous malformations of the face - venous and arteriovenous malformations of the face

Klinikum der Universität München, Campus Großhadern0 sites20 target enrollmentJanuary 20, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Q67.4
Sponsor
Klinikum der Universität München, Campus Großhadern
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Universität München, Campus Großhadern

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with lymphatic, arteriovenous or venous malformation of the face and having undergone image\-guided treatment by sclerotherapy or embolization in the form of one or more sessions in the period from 01/01/2017 to 12/30/2021\.
  • \- Patients who have received the above procedures with the following sclerotherapy/embolization agents: Polidocanol, (gelled) alcohol, EVOH\-based liquid embolization agents (EVOH \= ethylene vinyl alcohol copolymer), bleomycin, OK 432 (picibanil), doxycycline, STS (sodium tetradecyl sulfate).

Exclusion Criteria

  • \- Patients with lymphatic, arteriovenous or venous malformation without facial involvement.
  • \- Patients who have received other image\-guided interventional procedures, e.g., electrosclerotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials